InsidersTradesSigma
Follow the Celon Pharma S.A. stock price and the full management transaction log of the company, a publicly traded company based in Poland. Shares are listed on the PL market, under the supervision of KNF. Operating in the Health Care sector, Celon Pharma S.A. has recorded 2 public disclosures. Market capitalisation: €871.6m. The latest transaction was disclosed on 28 August 2026 (Purchase). Among the most active insiders: Justyna Rejmak. The full history is free.
Analysts rate Celon Pharma S.A. Hold (neutral), based on 5 analysts. Average price target: PLN 20.44.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Celon Pharma S.A. es una empresa centrada en el desarrollo de fármacos innovadores en el sector sanitario y farmacéutico. Cotiza en el mercado XWAR.